COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Investigator-Initiated Trial of Jaguar Health’s Crofelemer Yields Positive Results for Functional Diarrhea
Napo Pharmaceuticals announces positive results from a study on crofelemer, a plant-based prescription drug, for functional diarrhea patients, showing reduced abdominal pain and improved stool consistency -
-
-
COMMUNIQUÉ DE PRESSE
HBM portfolio company Yellow Jersey Therapeutics to be acquired for USD 1.25 billion
HBM Healthcare Investments announces Yellow Jersey Therapeutics acquisition by Johnson & Johnson for USD 1.25 billion. Transaction increases NAV per HBM share by CHF 8.70 (+3.5%) with expected cash inflow of USD 78 million -
COMMUNIQUÉ DE PRESSE
Mainz Biomed to Present New Pooled Colorectal Cancer Screening Data, its Largest Study to Date, at ASCO 2024 Annual Meeting
Mainz Biomed to present new pooled colorectal cancer screening data at ASCO 2024 Annual Meeting, showcasing significant advancements in early detection and diagnostic performance -
-
-
COMMUNIQUÉ DE PRESSE
Suralink Wins Gold in 2024 Titan Business Awards and Advances to International Accounting Awards Finals for Above-and-Beyond Customer Service
Suralink wins gold in Titan Business Awards' Customer Service Team of The Year category and is a finalist in International Accounting Awards, showcasing dedication to exceptional client services -
